High prevalence of hidradenitis suppurativa in patients with perianal fistula.

Christine B ArdonCharlotte MolenaarKelsey R van StraalenViolette C ScholtesErrol P PrensHessel H van der Zee

Published in: International journal of colorectal disease (2019)

The prevalence of HS in patients with a perianal fistula is at least 6.6%. This is higher than the prevalence reported in the general European population (1%) suggesting an association between perianal fistulas and HS. We stress the importance to screen for HS in patients with perianal fistulas in order to start appropriate anti-inflammatory treatment to reduce symptoms and disease progression.

Keyphrases

hidradenitis suppurativa
risk factors
anti inflammatory
high throughput
combination therapy
sleep quality
stress induced
depressive symptoms